Axe Compute Inc.
Axe Compute Inc. (AGPU) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Exhibit 99.1 Axe Compute Sells Helomics AI Cancer Diagnostics Lab Business to DataMEDS AI, Completing Transition to Neocloud GPU-as-a-Service platform September 15, 2026 All-stock sale gives Axe Compute equity stake in DataMEDS AI; aligns APU’s operating structure with its scalin
DataMeds AI, Inc. (MEDS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 PRESS RELEASE DATAMEDS AI, INC. 3000 BAYPORT DRIVE, SUITE 950 TAMPA, FLA. 33607 WEBSITE RUBENSTEIN PUBLIC RELATIONS CONTACT: JAMES LAMBERT 212-805-3024 JLAMBERT@RUBENSTEINPR.COM FOR IMMEDIATE RELEASE DATAMEDS, AI. ACQUIRES HELOMICS AI CANCER DIAGNOSTICS LAB AND PRECI
DataMEDS AI, Inc. (NASDAQ:MEDS) acquired Helomics, an AI cancer diagnostics lab, from Axe Compute (NASDAQ:AGPU) for $1.5 million in shares and notes. The deal includes a CLIA/CAP-certified lab and a precision oncology CRO business. DataMEDS plans to expand into cancer management, while Axe Compute focuses on AI infrastructure. The transaction has no third-party debt.
Over the past 7 days, AlphAI's AI scored 3 news stories mentioning AGPU (Axe Compute Inc.). Coverage has skewed bullish: 1 bullish, 2 neutral, and 0 bearish.
Recent AGPU coverage spans financial news, mergers & acquisitions and earnings.
In the last 30 days, AGPU insiders filed 2 SEC Form 4 transactions — 2 purchases ($98K) and no sales. The most active reporter was Zhu Theodore with 2 filings.
The divestiture removes a legacy business and provides AGPU with equity in DataMEDS, potentially boosting future upside while sharpening focus on core compute services.
Axe Compute will focus on its core AI‑infrastructure platform after divesting the cancer diagnostics unit.
Exit from cancer testing allows focus on core AI infrastructure business.
Small insider purchase may signal confidence but limited market impact due to low dollar amount.
Contract momentum and Build project economics (28% to 44% gross margins) suggest improving revenue visibility and potential margin durability.
AlphAI scores every news story that mentions AGPU with an AI model for sentiment and relevance, and aggregates insider trades from Axe Compute Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Axe Compute Inc. (AGPU) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Exhibit 99.1 Axe Compute Sells Helomics AI Cancer Diagnostics Lab Business to DataMEDS AI, Completing Transition to Neocloud GPU-as-a-Service platform September 15, 2026 All-stock sale gives Axe Compute equity stake in DataMEDS AI; aligns APU’s operating structure with its scalin
2 min readDataMeds AI, Inc. (MEDS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 PRESS RELEASE DATAMEDS AI, INC. 3000 BAYPORT DRIVE, SUITE 950 TAMPA, FLA. 33607 WEBSITE RUBENSTEIN PUBLIC RELATIONS CONTACT: JAMES LAMBERT 212-805-3024 JLAMBERT@RUBENSTEINPR.COM FOR IMMEDIATE RELEASE DATAMEDS, AI. ACQUIRES HELOMICS AI CANCER DIAGNOSTICS LAB AND PRECI
2 min readDataMEDS AI, Inc. (NASDAQ:MEDS) acquired Helomics, an AI cancer diagnostics lab, from Axe Compute (NASDAQ:AGPU) for $1.5 million in shares and notes. The deal includes a CLIA/CAP-certified lab and a precision oncology CRO business. DataMEDS plans to expand into cancer management, while Axe Compute focuses on AI infrastructure. The transaction has no third-party debt.
2 min readZhu Theodore purchased 8,750 shares of Axe Compute Inc. (AGPU) at an average of $11.24 ($10.88–$11.72) across 2 trades on 2026-09-08.
1 min readAxe Compute Inc (AGPU) reported $3 billion in new contracts for Q2 2026, exceeding expectations. CEO Christopher Miglino highlighted $3.2 billion in total contract value (TCV) year-to-date. The company expects gross margins of 28-44% and EBITDA margins of 62-76% for Build projects, funded by customer down payments and project financing. A partnership with Duos Technologies added 55 megawatts across multiple locations. The company received a $317 million prepayment for a cluster expansion in Colu
7 min readAxe Compute (Nasdaq: AGPU) and Duos Technologies (Nasdaq: DUOT) announced agreements for up to 55 MW of new AI data center capacity across multiple U.S. locations, with expected aggregate payments of over $500 million. Projects are targeted to start late 2026 into early 2027. Axe Compute also plans minority investments via nonbinding term sheets.
3 min readDuos Technologies Group (Nasdaq: DUOT) said two project entities signed five-year hosting agreements with Axe Compute (Nasdaq: AGPU) for 55 MW of AI data center capacity across multiple U.S. sites. The deals are valued at over $500 million in aggregate base payments over five years, excluding electricity and usage charges. Initial readiness is targeted for late 2026 to early 2027.
4 min readAxe Compute Inc. (AGPU) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Axe Compute Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update Revenue Grew More Than 90x Sequentially from Q1 2026 in the First Full Quarter of Compute Operations More Than $2.8 Billion in New Contracts Signed, Bringing 2026 Signed Contr
7 min readAxe Compute (NASDAQ:AGPU) said it secured a five-year $1.5 billion AI infrastructure contract. The deal includes a dedicated U.S. cluster with over 9,200 Nvidia (NASDAQ:NVDA) Blackwell B300 GPUs via its Axe Build program. The company expects $534 million in customer prepayments in 30 days, revenue starting this quarter, and annual run-rate above $696 million.
3 min readAxe Compute Inc. (NASDAQ: AGPU) said it was added to the Russell Microcap Index effective June 29, 2026, following the first 2026 semi-annual Russell U.S. indexes reconstitution. The Russell Microcap Index covers the smallest securities in the Russell 2000 by market cap. The company cited potential visibility and liquidity benefits; FTSE Russell uses market-cap rankings and style attributes.
2 min read
